PATENT CLAIM ANALYSIS

Application Number: 16037963
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-03
Patent Classification: ["424", "468000"]

Abstract:
Provided herein are methods for treating certain conditions, including diabetes, obesity, and other metabolic diseases, disorders or conditions by administrating a composition comprising a biguanide or related heterocyclic compound, e.g., metformin. Also provided herein are biguanide or related heterocyclic compound compositions, and methods for the preparation thereof for use in the methods of the present invention. Also provided herein are compositions comprising metformin and salts thereof and methods of use.

Claim (Index 77):
The method according to  claim 63 , wherein said pharmaceutical dosage form further comprises a second DPP-IV inhibitor.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 95.0
- Lexical Diversity: 1.90476
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14451323', '14370449', '15339378', '15339346', '13547022']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8952378690548958
- 35 USC 102 Novelty (BERT): 0.6596101609735233
- Combined Prediction Score: 0.8716750982467585
- Mean Citation Score: 902.605538
- Max Citation Score: 927.0892
- Similarity Product: 608.4783236396789

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test